The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The bank will allot 9.26 crore shares to the Government of India at a price not less than Rs.192.74/share
The company successfully completed of the acquisition of GSK's opiates manufacturing facilities in Australia
The stock moved higher by 6% to Rs 387 on the BSE.
Bank shares were among the top losers on concerns of lower net interest margins post cut in base rates
PNB, YES Bank, Canara Bank, HDFC Bank and Axis Bank from banking, L&T, Bharat Electronics were among the top losers from these two sectors
Hindalco, HDFC, L&T, Axis Bank and Bharti Airtel are the top five Sensex losers, falling between 2-3%
Post Q1 results, the stock rallied 30% compared to 8% decline in the S&P BSE Sensex.
The stock rallied 5% to Rs 233, extending its previous day's 6% surge on the BSE,
Here are a few stocks you need to keep a tab on for today
At 03:02 PM, the CNX Pharma index was up 2.3% or 279 points at 13,219 compared to a 0.20% decline in CNX Nifty.
Provisionally, the Sensex closed 83 points lower at 26,309 and the Nifty ended 31 points lower at 7,971
The board has approved an investment of Rs 1,281 crore to expand the Group's manufacturing facilities at Hassan.
Market participants are on the edge ahead of the Q1 GDP data, which is set to be released post market hours today
La Opala RG, Jubilant Life, 3M India, Chennai Petro, Ceat, Symphony, Escorts and FDC have rallied more than 15% each during the month.
The board has approved foreign currency borrowing limit upto $7.5 billion
The order from IOC worth Rs 1,094 crore is for EPCC package 2 at Haldia refinery
Lupin, Cipla, GAIL, Sun Pharma and ONGC are the top 5 gainers and are up between 1.5-2%
10 out of 12 sectoral indices are trading in green with BSE healthcare index up 1.5%
The RBI said that FIIs/RFPIs can buy up to 40% revised from earlier 35% of the paid up capital of Godrej under PIS
It got approval from the USFDA to manufacture and market Raloxifene Hydrochloride tablets USP 60 mg